← Back to Search

Topical Agent

TCA for Actinic Cheilitis

Phase 4
Waitlist Available
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion criteria will include all patients with actinic cheilitis that do not meet
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial compared the efficacy of TCA versus Placebo in the treatment of actinic cheilitis.

Eligible Conditions
  • Actinic Cheilitis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Recurrence Rate
Remission rate
+1 more
Secondary outcome measures
Healing Time
patient satisfaction

Trial Design

1Treatment groups
Experimental Treatment
Group I: TCA pealExperimental Treatment1 Intervention
Patients will have their actinic cheilitis treated with a TCA peal.

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
255 Previous Clinical Trials
83,589 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the capacity for this clinical experiment?

"Affirmative. Clinicaltrials.gov has recorded that this clinical trial, which was initially posted on March 10th 2021, is currently recruiting participants. Altogether 50 people are required for the study at only one location."

Answered by AI

Is there still room for participants in this experiment?

"Evidenced by information hosted on clinicaltrials.gov, this clinical investigation is currently enrolling participants and has been active since March 10th 2021. The details of the trial have been amended as recently as August 12th 2021."

Answered by AI

Has the Food and Drug Administration given its stamp of approval for tricyclic antidepressants?

"Per our assessment, TCA has been granted a safety rating of 3 due to its success in Phase 4 trials and subsequent approval."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
S Mark Taylor 2021. "Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04744103.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top